Sarlon Intranasal Racemic Ketamine

Published: 22 January 2025| Version 1 | DOI: 10.17632/yrn899kfgk.1
Contributor:
Jan Sarlon

Description

Dataset of 45 patients who completed an ambulant induction phase of ketamine-therapy with intranasal racemic ketamine. We assessed the tolerability and efficacy.

Files

Institutions

Universitat Basel

Categories

Clinical Psychiatry

Licence